SandersJ, EvansM, BetterleC, SandersP, BhardwajaA, YoungS, RobertsE, WilmotJ, RichardsT, KiddieA, SmallK, PlattH, SummerhayesS, HarrisR, ReeveM, CocoG, ZanchettaR, ChenS, FurmaniakJ, SmithBR. 2008. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Thyroid, 18:735–746.
2.
InabaH, PanD, ShinYH, MartinW, BuchmanG, DeGrootLJ. 2009. Immune response of mice transgenic for human histocompatibility leukocyte antigen-DR to human thyrotropin receptor-extracellular domain. Thyroid, 19:1271–1280.
3.
LiuD, XingM. 2008. Potent inhibition of thyroid cancer cells by the MEK inhibitor PD0325901 and its potentiation by suppression of the PI3K and NF-kappa B pathways. Thyroid, 18:853–864.
4.
TuttleRM, LukesY, OnstadL, LushnikovE, AbrosimovA, TroshinV, TsybA, DavisS, KopeckyKJ. Francis, 2008 ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout. Thyroid, 18:839–846.
LohJA, WartofskyL, JonklaasJ, BurmanKD. 2009. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid, 19:269–275.
7.
RiveraM, TuttleRM, PatelS, ShahaA, ShahJP, GhosseinRA. 2009. Encapsulated papillary thyroid carcinoma: a clinic-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern)Thyroid, 19:119–127.
8.
WilliamsED, AbrosimovA, BogdanovaT, DemidchikEP, ItoM, LiVolsiV, LushnikovE, RosaiJ, TronkoMD, TsybAF, VowlerSL, ThomasGA. 2008. Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake. Thyroid, 18:847–852.
